Graves' disease and hyperthyroidism trials in New Zealand

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  Where

  Auckland, Wellington

  Age

  18 years to 75 years

  People

  210 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07018323 · EU 2025-521920-31-00